id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-3240-0376,FDA,FDA-2018-N-3240,"Reference 1 - FDA Proposal Not to Include Ephedrine Sulfate on the 503B Bulks List RE List of Bulk Drug Substances for Which There is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act",Supporting & Related Material,Background Material,2023-08-28T04:00:00Z,2023,8,,,2023-08-28T16:19:35Z,,0,0,0900006485f02240
FDA-2018-N-3240-0375,FDA,FDA-2018-N-3240,"Reference 3 - Part 1 Evaluation for Hydroxychloroquine Sulfate RE List of Bulk Drug Substances for Which There is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act",Supporting & Related Material,Background Material,2023-08-23T04:00:00Z,2023,8,,,2023-08-23T20:14:40Z,,0,0,0900006485edb7aa
FDA-2018-N-3240-0374,FDA,FDA-2018-N-3240,"Reference 2 - Supplemental clinical need evaluation for ephedrine sulfate in compounding under section 503B of the Federal Food, Drug, and Cosmetic Act RE List of Bulk Drug Substances for Which There is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act",Supporting & Related Material,Background Material,2023-08-21T04:00:00Z,2023,8,,,2023-08-21T19:04:48Z,,0,0,0900006485ecb128
FDA-2018-N-3240-0373,FDA,FDA-2018-N-3240,"List of Bulk Drug Substances for Which There is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act",Notice,General Notice,2023-08-21T04:00:00Z,2023,8,,,2023-08-21T12:58:21Z,2023-17881,0,0,0900006485ec9ee6
FDA-2018-N-3240-0371,FDA,FDA-2018-N-3240,"List of Bulk Drug Substances for Which There Is a Clinical Need Under
Section 503B of the Federal Food, Drug, and Cosmetic Act",Notice,Announcement,2023-04-06T04:00:00Z,2023,4,2023-04-06T04:00:00Z,,2023-04-10T14:30:49Z,2023-07217,0,0,09000064858f25e1
FDA-2018-N-3240-0372,FDA,FDA-2018-N-3240,"Reference 4 re: List of Bulk Drug Substances for Which There Is a Clinical Need Under the Federal Food, Drug, and Cosmetic Prescription Requirements Under Section 503 A Under the Federal Food Drug and Cosmetic Act",Supporting & Related Material,Background Material,2023-04-06T04:00:00Z,2023,4,,,2023-04-06T15:50:49Z,,0,0,09000064858f2ed2